Piotr Zimniak, Ph.D.
A. POSITIONS
AND HONORS
Professional Experience
1981-1985 Assistant Prof., Dept. Biochem. and
Pharmacol., Tufts Univ. Sch. Med., Boston, MA
1985-1988 Assistant Prof., Dept. Int. Med., Univ.
of Texas Med. Sch., Houston, TX
1988-1988 Joint appt. as Assist. Prof., Dept.
Bioch. and Molec. Biol., Univ. of Texas Med. Sch., Houston, TX
1988-1989 Assistant Prof., Dept. of Med., Univ.
of Rochester Sch. Med., Rochester, NY
1989-1989 Visiting Prof., Biocenter of the Univ.
Basel, Switzerland
1989-1997 Associate Prof., Dept. Int. Med., Univ.
of Arkansas Med. Sci., Little Rock, AR
1991-1997 Joint appt. as Assoc. Prof., Dept.
Bioch. and Molec. Biol., Univ. of Ark. Med. Sci., Little Rock, AR
1997-2002 Professor, Dept. of Int. Med., and
Dept. of Bioch. and Molec. Biol., Univ. of Ark. Med. Sci., Little Rock, AR
2002-present Professor, Dept. Pharm./Tox., and Depts.
Bioch. & Mol. Biol., and Int. Med.., Univ. of Ark. Med. Sci.
Professional Organizations
1982-present American Society of Biochemistry and
Molecular Biology
1982-present New York Academy of Sciences
1985-present American Chemical Society
1986-present American Association for the Advancement of
Science
Study Section Membership
1996-2000 NIH ALTX-1 Study Section (ad hoc
1996-97, permanent from fall 1997-summer 2000)
1996-2000 VA Gastroenterology Merit Review Board
(ad hoc 1996-97; permanent 1997-2000)
June 2003 Member of NIH Review Panel for RFA
entitled "Comparative Biology: Mechanisms of Aging", NIA.
Dec. 2003 Member of NIH NIA Review Panel for a
Program Project grant.
Nov. 2004 Ad hoc member of NIH CICS (Clinical and
Integrative Cardiovascular Science) Study Section.
B. SELECTED
PEER-REVIEWED PUBLICATIONS (OUT OF 140)
Cheng K, Chen Y, Zimniak P, Raufman J-P,
Xiao Y, Frucht H. Functional interaction of lithocholic acid conjugates with M3
muscarinic receptors on a human colon cancer cell line. Biochim. Biophys. Acta 1588(1): 48-55, 2002.
Yang Y, Sharma R, Zimniak P, Awasthi YC.
Role of a
class glutathione S-transferases as antioxidant enzymes in rodent tissues.
Toxicol. Appl. Pharmacol. 182: 105-115, 2002.
Singh
SP, Janecki AJ, Srivastava SK, Awasthi S, Awasthi YC, Xia SJ, Zimniak P.
Membrane association of glutathione S-transferase mGSTA4-4, an enzyme that
metabolizes lipid peroxidation products. J. Biol. Chem. 277: 4232, 2002.
Sharma
R, Sharma A, Yang Y, Awasthi S, Singhal SS, Zimniak P, Awasthi YC.
Functional reconstitution of Ral-binding GTPase activating protein, RLIP76, in
proteoliposomes catalyzing ATP-dependent transport of glutathione conjugate of
4-hydroxynonenal. Acta Biochim. Pol. 49:
693-701, 2002.
Guo
J, Zimniak L, Zimniak P, Orchard JL, Singh SV. Cloning and expression of
a novel Mu class murine glutathione transferase isoenzyme. Biochem. J.366: 817-824, 2002.
Cheng
KR, Khurana S, Chen Y, Kennedy RH, Zimniak P, Raufman JP.
Lithocholylcholine, a bile acid/acetylcholine hybrid, is a muscarinic receptor
antagonist. J. Pharm. Expt. Ther. 303:
29-35, 2002.
Awasthi
S, Sharma R, Singhal SS, Zimniak P, Awasthi YC. RLIP76, a novel
transporter catalyzing ATP-dependent efflux of xenobiotics. Drug Metabol. Disp.
30: 1300-1310, 2002.
Awasthi
S, Sharma R, Yang YS, Singhal SS, Pikula S, Bandorowicz-Pikula J, Singh SV, Zimniak
P, Awasthi YC. Transport functions and physiological significance of 76 kDa
Ral-binding GTPase activating protein (RLIP76). Acta Biochim. Pol. 49: 855-867,
2002.
Bose
C, Guo JX, Zimniak L, Srivastava SK, Singh SP, Zimniak P, Singh SV.
Critical role of allyl groups, and disulfide chain in induction of Pi class
glutathione transferase in mouse tissues in vivo by diallyl disulfide, a
naturally occurring chemopreventive agent in garlic. Carcinogenesis 23: 1661-1665, 2002.
Raufman
JP, Chen Y, Cheng KR, Compadre C, Compadre L, Zimniak P. Selective
interaction of bile acids with muscarinic receptors: a case of molecular
mimicry. Eur. J. Pharmacol. 457:
77-84, 2002.
Sawicki
R, Singh SP, Mondal AK, Benes H, Zimniak P. Cloning, expression, and
biochemical characterization of one Epsilon-class (GST-3) and ten Delta-class
(GST-1) glutathione S-transferases from Drosophila
melanogaster, and identification of additional nine members of the Epsilon
class. Biochem. J. 370: 661-669,
2003.
Awasthi
S, Singhal SS, Sharma R, Zimniak P, Awasthi YC. Transport of
glutathione-conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel
link between G-protein and tyrosine kinase signaling and drug resistance.
Internat. J. Cancer 106: 635-646,
2003.
Singhal SS, Singhal J, Sharma R, Singh SV, Zimniak
P, Awasthi YC, Awasthi S. Role of RLIP76 in lung cancer doxorubicin
resistance: I. The ATPase activity of RLIP76 correlates with doxorubicin and
4-hydroxynonenal resistance in lung cancer cells. Int. J. Oncol. 22:
365-375, 2003.
Awasthi S, Singhal SS, Singhal J, Cheng J, Zimniak
P, Awasthi YC. Role of RLIP76 in lung cancer doxorubicin resistance: II.
Doxorubicin transport in lung cancer by RLIP76. Int. J. Oncol. 22:
713-720, 2003.
Awasthi S, Singhal SS, Singhal J, Yang Y, Zimniak
P, Awasthi YC. Role of RLIP76 in lung cancer doxorubicin resistance: III.
Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and
synergistically increase doxorubicin cytotoxicity. Int. J. Oncol. 22:
721-732, 2003.
Raufman JP, Cheng K, Zimniak P. Activation
of muscarinic receptor signaling by bile acids – physiological and medical
implications. Dig. Dis. Sci. 48:
1431-1444, 2003.
Yang
Y, Sharma A, Sharma R, Patrick B, Singhal SS, Zimniak P, Awasthi S,
Awasthi YC. Cells
preconditioned with mild, transient UVA irradiation acquire resistance to
oxidative stress and UVA-induced apoptosis: Role of 4-hydroxynonenal in UVA
mediated signaling for apoptosis. J. Biol. Chem. 278: 41380-41388, 2003.
Cheng
KR, Zimniak P, Raufman JP. Transactivation of the epidermal growth factor receptor
mediates cholinergic agonist-induced proliferation of H508 colon cancer cells.
Cancer Res.63: 6744-6750, 2003.
Engle
MR, Singh SP, Czernik PJ, Gaddy D, Montague DC, Ceci JD, Yang Y, Awasthi S,
Awasthi YC, Zimniak P. Physiological role of mGSTA4-4, a glutathione
S-transferase metabolizing 4 hydroxynonenal: generation and analysis of mGsta4 null mouse. Toxicol. Appl.
Pharmacol. 194: 296-308, 2004.
Yang
Y, Yang Y, Trent MB, He N, Lick SD, Zimniak P, Awasthi YC, Boor PJ.
Glutathione-S-transferase A 4-4 modulates oxidative stress in endothelium:
possible role in human atherosclerosis. Atherosclerosis 173: 211-21, 2004.
Sharma
R, Brown D, Awasthi S, Yang Y, Sharma A, Patrick B, Saini MK, Singh SP, Zimniak
P, Singh SV, Awasthi YC. Transfection with 4-hydroxynonenal metabolizing
glutathione S-transferase isozymes leads to phenotypic transformation and
immortalization of adherent cells. Eur. J. Bioch.271 1690-1701, 2004.
Singh
SV, Varma V, Zimniak P, Srivastava SK, Marynowski SW, Desai D, Amin S,
Ji X. Structural basis for catalytic differences between Alpha class human
glutathione transferases hGSTA1-1 and hGSTA2-2 for glutathione conjugation of
environmental carcinogen benzo[a]pyrene-7,8-diol-9,10-epoxide. Biochemistry 43: 9708-9715, 2004.
Wu
Z, Minhas GS, Wen D, Jiang H, Chen K, Zimniak P, Zheng J. Design,
synthesis, and structure-activity relationships of haloenol lactones:
site-directed and isozyme-selective glutathione S-transferase inhibitors. J.
Medicinal Chem. 47: 3282-3294, 2004.
Gu
Y, Guo J, Pal A, Pan S-S, Zimniak P, Singh SV, Ji X. Crystal structure of human glutathione
S-transferase A3-3 and mechanistic implications for its high steroid isomerase
activity. Biochemistry 43:15673-15679,
2004.
Singh
SP, Chen T, Chen L, Mei N, McLain E, Samokyszyn V, Thaden JJ, Moore MM, Zimniak
P. Mutagenic effects of 4-hydroxynonenal triacetate, a chemically protected
form of the lipid peroxidation product 4-hydroxynonenal, as assayed in L5178Y Tk+/- mouse lymphoma cells.
J. Pharm. Expt. Ther. 313: 855-861, 2005.
McEwen
JE, Zimniak P, Mehta JL, Shmookler Reis RJ. Molecular pathology of aging and its implications for senescent
coronary atherosclerosis. Curr. Opin.
Cardiol. 20: 399-406, 2005
Patrick
B, Li J, Jeyabal PVS, Reddy PMRV, Yang YS, Sharma R, Sinha M, Luxon B, Zimniak
P, Awasthi S, Awasthi YC. Depletion of 4-hydroxynonenal in
hGSTA4-transfected HLE B-3 cells results in profound changes in gene
expression. Biochem. Biophys. Res. Commun. 334: 425–432, 2005.
Ayyadevara
S, Engle MR, Singh SP, Dandapat A, Lichti CF, Benes H, Shmookler Reis RJ,
Liebau E, Zimniak P. Life span and stress resistance of Caenorhabditis elegans are increased by
expression of glutathione transferases capable of metabolizing the lipid
peroxidation product 4-hydroxynonenal. Aging Cell 4: 257-271, 2005.
C. RESEARCH
SUPPORT
Ongoing research support
|
R01
AG 18845-01 (Zimniak, PI)
|
3/1/02
- 2/28/07
|
|
|
NIH/NIA
|
$250,000
|
|
|
Role
of lipid peroxidation and 4-hydroxynonenal in aging
|
|
|
Major
goals: To create transgenic Drosophila lines with inducible and tissue-specific
expression of several mammalian GSTs, some of which have the ability to
conjugate 4-hydroxynonenal or to reduce lipid hydroperoxides. The lines will
be used to evaluate, under normal and stressed conditions, the effects of
4-hydroxynonenal metabolism on biochemical markers of aging and on life span.
|
|
|
Role:
PI
|
|
|
|
|
|
|
R01
ES 07804-06 (Zimniak, PI)
|
8/1/96
- 7/31/06
|
|
|
NIH/NIEHS
|
$250,000
|
|
|
Glutathione
transferases and oxidative stress toxicology
|
|
Major
goals: To characterize the physiological role of 4-hydroxynonenal metabolism
catalyzed by mGSTA4-4 in a knockout mouse lacking the enzyme, and in
transfected cells. To continue structure-function relationship studies on
mGSTA4-4.
|
|
Role:
PI
|
|
R01
ES 09140 (S.V. Singh, PI / P.Zimniak, subcontract PI)
|
2002-2006
|
|
|
NIH/NIEHS
|
$72,792
subcontract direct costs
|
|
|
Toxicological
relevance of human GST P1-1 polymorphism
|
|
Major
goals: The application is based on our previous finding that allelic forms of
hGSTP1-1 exhibit differential activity toward benzo[a]pyrene diol epoxide, a
known cigarette smoke and environmental carcinogen, and similar PAHs. Allelic forms of hGSTP1-1 will be
characterized in knock-in mice and in transfected cells.
|
|
Role:
Subcontract PI
|
|
R01
AG 18845S (Zimniak, PI)
|
3/1/02
- 2/28/07
|
|
|
NIH/NIA
|
$80,000
|
|
|
Murine
transgenic models of genetic alterations attenuating metabolic damage and
extending longevity in invertebrates (Supplement to: Role of lipid
peroxidation and 4-hydroxynonenal in aging)
|
|
Major
goals: To investigate whether genes whose mutations modulate life span in
invertebrates have the same effect in mice.
|
|
Role:
PI
|
Completed research support
|
no
project number (Zimniak, PI)
|
10/1/92
- 9/31/04
|
|
|
VA
|
$194,900
|
|
|
Mechanisms
of hepatic transport of organic anions
|
|
Major
goals: To characterize biochemically and physiologically a novel
ATP-dependent organic anion transporter of liver canalicular membranes.
|
|
Role:
PI
|
|
Zimniak,
PI
|
7/1/2004
- 6/30/2005
|
|
|
Arkansas
Tobacco Settlement Fund
|
$24,300
|
|
|
Microarray
analysis of differences between control and mGsta4 null mice
|
|
Major
goals: To determine differences in gene expression patterns between control
and mGsta4 null mice
|
|
Role:
PI
|